39098 Federal Register / Vol. 87, No. 125 / Thursday, June 30, 2022 / Notices 

Without pulse surveys, it will be 

difficult to measure changes employee 

sentiment on critical PMA issues in a 

short time frame. Having three pulses 

allows us to trend questions as 

conditions change. 

Technical experts will review and 

approve the survey content. 

Some questions may be asked that are 

of a personal or sensitive nature (e.g., 

questions on Diversity, Equity, 

Inclusion, and Accessibility). 

B. Annual Reporting Burden 

Respondents: 367,000. 

Responses Per Respondent: 1. 

Total Annual Responses: 3. 

Hours per Response: 0.0106 (38 

seconds). 

Total Burden Hours: 11,621.67. 

C. Public Comments 

GSA invites comments on: whether 

this collection of information is 

necessary, whether it will have practical 

utility; whether our estimate of the 

public burden of this collection of 

information is accurate, and based on 

valid assumptions and methodology; 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and ways in which we can 

minimize the burden of the collection of 

information on those who are to 

respond, through the use of appropriate 

technological collection techniques or 

other forms of information technology. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the Regulatory Secretariat Division by 

calling 202–501–4755 or emailing 

GSARegSec@gsa.gov. Please cite OMB 

Control No. ‘‘3090–XXXX Generic 

Clearance for the Collection of the 

Government-wide Pulse Survey’’ in all 

correspondence. 

Beth Anne Killoran, 

Deputy Chief Information Officer. 

[FR Doc. 2022–13988 Filed 6–29–22; 8:45 am] 

BILLING CODE 6820–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Sexual Risk Avoidance 

Education Performance Analysis 

Study—Extension (Office of 

Management and Budget (OMB) 

#0970–0536) 

AGENCY: Office of Planning, Research, 

and Evaluation (OPRE), Administration 

for Children and Families (ACF), U.S. 

Department of Health and Human 

Services (HHS). 

ACTION: Request for public comment. 

SUMMARY: OPRE and the Family and 

Youth Services Bureau (FYSB) request 

an extension without changes to a 

currently approved information 

collection activity as part of Sexual Risk 

Avoidance Education Performance 

Analysis Study (SRAE PAS)(OMB 

Control No. 0970–0536; expiration date 

October 31, 2022). The goal of the study 

is to collect, analyze, and report on 

performance measures data for the 

SRAE program. 

DATES: Comments are due within 60 

days of publication. In compliance with 

the requirements of the Paperwork 

Reduction Act (PRA) of 1995, ACF is 

soliciting public comment on the 

specific aspects of the information 

collection described above. 

ADDRESSES: You can obtain copies of the 

proposed collection of information and 

submit comments by emailing 

opreinfocollection@acf.hhs.gov. Identify 

all requests by the title of the 

information collection. 

SUPPLEMENTARY INFORMATION:

Description: The purpose of the SRAE 

program is to educate youth on how to 

voluntarily refrain from nonmarital 

sexual activity and prevent other youth 

risk behaviors. The requested extension 

will allow ACF to continue to collect 

the performance measures from SRAE 

grantees. Data will continue to be used 

to determine if the SRAE grantees are 

meeting performance benchmarks 

related to their program’s mission and 

priorities. The program office will 

continue to use the data to provide 

technical assistance to grantees and for 

its own reporting purposes. 

Respondents: Departmental Sexual 

Risk Avoidance Education (DSRAE), 

State Sexual Risk Avoidance Education 

(SSRAE), and Competitive Sexual Risk 

Avoidance Education (CSRAE) grantees, 

their sub recipients, and program 

participants. 

ANNUAL BURDEN ESTIMATES

Instrument 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses per 

respondent 

(total over 

request 

period) 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Annual burden 

(in hours) 

(1) Participant Entry Survey 

DSRAE participants ............................................................. 378,390 1 0.1333 50,439 16,813 

SSRAE participants ............................................................. 952,899 1 0.1333 127,021 42,340 

CSRAE participants ............................................................. 60,408 1 0.1333 8,052 2,684 

(2) Participant Exit Survey 

DSRAE participants ............................................................. 302,712 1 0.1667 50,462 16,821 

SSRAE participants ............................................................. 762,319 1 0.1667 127,079 42,360 

CSRAE participants ............................................................. 48,326 1 0.1667 8,056 2,685 

(3) Performance reporting data entry form: grantees 

DSRAE grantees .................................................................. 119 6 16 11,424 3,808 

SSRAE grantees .................................................................. 39 6 16 3,744 1,248 

CSRAE grantees .................................................................. 34 6 16 3,264 1,088 

(4) Performance reporting data entry form: subrecipients 

DSRAE subrecipients .......................................................... 252 6 13 19,656 6,552 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 125 / Thursday, June 30, 2022 / Notices 39099 

ANNUAL BURDEN ESTIMATES—Continued 

Instrument 

Number of 

respondents 

(total over 

request 

period) 

Number of 

responses per 

respondent 

(total over 

request 

period) 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Annual burden 

(in hours) 

SSRAE subrecipients ........................................................... 426 6 13 33,228 11,076 

CSRAE subrecipients .......................................................... 63 6 13 4,914 1,638 

Estimated Total Annual Burden 

Hours: 149,113. 

Comments: The Department 

specifically requests comments on (a) 

whether the proposed collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information shall have practical utility; 

(b) the accuracy of the agency’s estimate 

of the burden of the proposed collection 

of information; (c) the quality, utility, 

and clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Consideration will be given 

to comments and suggestions submitted 

within 60 days of this publication. 

Authority: 42 U.S.C. 1310. 

Mary B. Jones, 

ACF/OPRE Certifying Officer. 

[FR Doc. 2022–14026 Filed 6–29–22; 8:45 am] 

BILLING CODE 4184–83–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2020–E–2251] 

Determination of Regulatory Review 

Period for Purposes of Patent 

Extension; TEPEZZA 

AGENCY: Food and Drug Administration, 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or the Agency) has 

determined the regulatory review period 

for TEPEZZA and is publishing this 

notice of that determination as required 

by law. FDA has made the 

determination because of the 

submission of an application to the 

Director of the U.S. Patent and 

Trademark Office (USPTO), Department 

of Commerce, for the extension of a 

patent which claims that human 

biological product. 

DATES: Anyone with knowledge that any 

of the dates as published (see 

SUPPLEMENTARY INFORMATION) are 

incorrect may submit either electronic 

or written comments and ask for a 

redetermination by August 29, 2022. 

Furthermore, any interested person may 

petition FDA for a determination 

regarding whether the applicant for 

extension acted with due diligence 

during the regulatory review period by 

December 27, 2022. See ‘‘Petitions’’ in 

the SUPPLEMENTARY INFORMATION section 

for more information. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. Electronic comments must 

be submitted on or before August 29, 

2022. The https://www.regulations.gov 

electronic filing system will accept 

comments until 11:59 p.m. Eastern Time 

at the end of August 29, 2022. 

Comments received by mail/hand 

delivery/courier (for written/paper 

submissions) will be considered timely 

if they are postmarked or the delivery 

service acceptance receipt is on or 

before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand Delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2020–E–2251 for ‘‘Determination of 

Regulatory Review Period for Purposes 

of Patent Extension; TEPEZZA.’’ 

Received comments, those filed in a 

timely manner (see ADDRESSES), will be 

placed in the docket and, except for 

those submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday, 240–402–7500. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 


jspears on DSK121TN23PROD with NOTICES1